Dr. Crystal Icenhour: Leader of The Science Advisory Board’s Next-Generation Sequencing Team
Dr. Icenhour earned her Ph.D. in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School of Graduate Studies in 2002. She went on to conduct postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College of Medicine and in the Department of Infectious Diseases at Duke University Medical Center.
“I’m excited to lead the Science Advisory Board’s Next-Generation Sequencing Team. I look forward to working with my colleagues on the board to explore the increasing power of NGS technologies.”
Dr. Icenhour went on to co-found Phthisis Diagnostics, located in Charlottesville, Virginia. She served as President & Chief Science Officer from 2006 to 2013. Phthisis Diagnostics’ mission was to develop and commercialize easy-to-use, cost effective molecular diagnostics with a focus on diseases of public health importance and on facilitating clinical adoption of modern, accurate diagnostics. The company offered a range of innovative molecular diagnostic products designed for total nucleic acid extraction and molecular standards for quality control. Phthisis Diagnostics was acquired by Microbiologics, Inc. in October 2013.
“My professional goal is to bridge the translational gap between the two worlds of business and science. Leadership, innovation, and commercialization are my passion.”
In 2014, Dr. Icenhour became CEO of Aperiomics, Inc. in Ashburn, Virginia. Aperiomics’ focus is to harness the power of next-generation sequencing to improve world health. Its mission is to detect any pathogen from human, agricultural, or environmental samples. The company’s service platform provides a combination of next-generation sequencing and advanced bioinformatic data analysis to detect pathogens. Aperiomics’ service focuses on pathogens of public and animal health importance, satisfying the increasing need for robust and efficient next-generation sequencing data analysis. Aperiomics’ platform is a perfect fit for pathogen discovery, difficult cases of unknown etiology, pathogen surveillance and monitoring, as well as routine pathogen detection.
In addition to her scientific contributions, Dr. Icenhour has been actively involved in local and national postdoctoral associations. She served as President of the Mayo Research Fellows Association Executive Committee and as Membership Committee Chair for the Duke University Postdoctoral Association. In 2008, she expanded her influence by serving as Chair for the U.S. National Postdoctoral Association.
Click Here For more information
on The Science Advisory Board